-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J7LtblmNeoBop+ukVR6Ry9w39gVYGbx+pHTG1JB6/lzctJeHuJzfssYGh/6sMk2h jBQfFwCSvKIWkqyx4iClEA== 0001209191-03-021670.txt : 20030915 0001209191-03-021670.hdr.sgml : 20030915 20030915192117 ACCESSION NUMBER: 0001209191-03-021670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030911 FILED AS OF DATE: 20030915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TESI RAYMOND J CENTRAL INDEX KEY: 0001221597 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22890 FILM NUMBER: 03896563 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGSTAT MEDICAL CORP CENTRAL INDEX KEY: 0000913610 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943076069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5107894300 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc4.xml FORM 4 SUBMISSION X0201 42003-09-111 0000913610 SANGSTAT MEDICAL CORP SANG 0001221597 TESI RAYMOND J 6300 DUMBARTON CIRCLE FREMONT CA 94555 0100VP MarketingCommon Stock2003-09-114D0520022.5D0DCommon Stock2003-09-114M0200020A2000DCommon Stock2003-09-114D0200022.5D0DCommon Stock2003-09-114M0212420A2124DCommon Stock2003- 09-114D0212422.5D0DCommon Stock2003-09-114M0280020A2800DCommon Stock2003-09-114D0280022.5D0DCommon Stock2003-09-114M0300020A3000DCommon Stock2003-09-114D0300022.5D0DCommon Stock2003-09-114M03200< value>20A3200DCommon Stock2003-09-114D0320022.5D0DCommon Stock2003-09-114M0400020A4000DCommon Stock2003-09-114D0400022.5D0DCommon Stock2003-09-114M0500020A5000DCommon Stock2003-09-114D0500022.5D0DCommon Stock2003-09-114M01587620A15876DCommon Stock2003-09-114D01587622.5D0DCommon Stock2003-09-114M0100019.75A1000DCommon Stock2003-09-114D0100022.5D0DCommon Stock2003-09-114M0817712.125A8177DCommon Stock2003-09-114D0817722.5D0DCommon Stock2003-09-114M0982312.125A9823DCommon Stock2003-09-114D0982322.5D0DCommon Stock2003-09-114M058017.25A580DCommon Stock2003-09-114D058022.5D0DCommon Stock2003-09-114M0142017.25A1420DCommon Stock2003-09-114D0142022.5D0DCommon Stock2003-09-114M0300017.25A3000D< securityTitle>Common Stock2003-09-114D0300022.5D0DOptions to Purch ase Common Stock202003-09-114M0200022.5D2003-09-112007-05-09Common Stock20000DOptions to Purchase Common Stock202003-09-114M0212422.5D2003-09-112007-05-09Common Stock21240DOptions to Purchase Common Stock202003-09-114M0280022.5D2003-09-112007-05-09Common Stock28000DOptions to Purchase Common Stock202003-09-114M0300022.5D2003-09-112007-05-09Common Stock30000DOptions to Purchase Common Stock202003-09-114M0320022.5D2003-09-112007-05-09Common Stock32000DOptions to Purchase Common Stock202003-09-114M0400022.5D2003-09-112007-05-09Common Stock40000DOptions to Purchase Common Stock202003-09- 114M0500022.5D2003-09-112007-05-09Common Stock50000< directOrIndirectOwnership>DOptions to Purchase Common Stock202003-09-114M01587622.5D2003-09-112007-05-09Common Stock158760DOptions to Purchase Common Stock19.752003-09-114M0100022.5D2003-09-112008-10-07Common Stock10000DOptions to Purchase Common Stock12.1252003-09-114M0817722.5D2003-09-112009-05-04Common Stock81770DOptions to Purchase Common Stock12.1252003-09-114M0982322.5D2003-09-112009-05-04Common Stock98230DOptions to Purchase Common Stock17.252003-09-114M058022.5D2003-09-112009-06-30Common Stock5800DOptions to Purchase Common Stock17.252003-09-114M0142022.5D2003-09-112009-06-30Common Stock14200DOptions to Purchase Common Stock17.252003-09-114M0300022.5D2003-09-112009-06-30Common Stock30000DOption vesting was accelerated and the underlying common stock and all other common stock owned by the reporting person was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.FORM 4 [1 of 2] See attached footnote page.Tamiko F. Lewis, Attorney-in-Fact for Raymond J. Tesi2003-09-15 -----END PRIVACY-ENHANCED MESSAGE-----